I agree that this site is using cookies. You can find further informations here.
X
Merkliste 
 1 Ergebnisse 
 
1

Phase I trial of the MEK inhibitor selumetinib in combinati..:

Haslett, K. ; Koh, P. ; Hudson, A....
Clinical and Translational Radiation Oncology.  28 (2021)  - p. 24-31 , 2021
Link: https://doi.org/10.1016/j.ctro.2021.02.008